Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of F8 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of F8 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of F8 mRNA | increases expression | 18648102
|
D000535 |
Aluminum |
Aluminum affects the folding of F8 protein | affects folding | 15349964
|
D000535 |
Aluminum |
[Aluminum promotes the reaction [F8 protein binds to F8 protein]] which results in decreased activity of F8 protein | affects binding|decreases activity|increases reaction | 15349964
|
D044966 |
Anti-Retroviral Agents |
Anti-Retroviral Agents results in decreased expression of F8 protein | decreases expression | 19929230
|
D002118 |
Calcium |
Calcium results in increased activity of [F8 protein alternative form binds to F8 protein alternative form] | affects binding|increases activity | 11513607
|
D002118 |
Calcium |
[Copper co-treated with Calcium] results in increased activity of [F8 protein alternative form binds to F8 protein alternative form] | affects binding|affects cotreatment|increases activity | 11513607
|
D003300 |
Copper |
[Copper co-treated with Calcium] results in increased activity of [F8 protein alternative form binds to F8 protein alternative form] | affects binding|affects cotreatment|increases activity | 11513607
|
D003300 |
Copper |
Copper promotes the reaction [F8 protein alternative form binds to F8 protein alternative form] | affects binding|increases reaction | 11513607
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of F8 mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] affects the activity of F8 protein | affects activity|affects cotreatment | 11720199
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of F8 protein | affects cotreatment|increases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F8 protein | affects cotreatment|increases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F8 protein | affects cotreatment|increases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of F8 mRNA | increases expression | 17555576 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of F8 mRNA | affects cotreatment|increases expression | 17942748
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased expression of F8 protein | increases expression | 12618251
|
D005472 |
Fluorouracil |
F8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] | affects cotreatment|increases response to substance | 17327601
|
D002955 |
Leucovorin |
F8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] | affects cotreatment|increases response to substance | 17327601
|
D005839 |
Gentamicins |
Gentamicins results in increased expression of F8 protein | increases expression | 16051741
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] affects the activity of F8 protein | affects activity|affects cotreatment | 11720199
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of F8 protein | affects cotreatment|increases expression | 12618251
|
C051890 |
irinotecan |
F8 mRNA results in increased susceptibility to [Leucovorin co-treated with Fluorouracil co-treated with irinotecan] | affects cotreatment|increases response to substance | 17327601
|
C017576 |
norgestimate |
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of F8 protein | affects cotreatment|increases expression | 12618251
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F8 protein | affects cotreatment|increases expression | 12618251
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of F8 mRNA] | affects reaction|decreases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of F8 mRNA | decreases expression | 19482888
|
D020849 |
Raloxifene |
Raloxifene results in increased activity of F8 protein | increases activity | 16359964
|
D020849 |
Raloxifene |
Raloxifene results in increased expression of F8 protein | increases expression | 15850603
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of F8 protein | increases expression | 15850603
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of F8 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of F8 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.44 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.93 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.93 | 11752688 14514962 15322242 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
11.97 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
norgestimate |
11.97 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Gentamicins |
4.44 | 11274264 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.25 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.25 | 17638652 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.69 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
9.72 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.72 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.49 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Aluminum |
6.84 | 17662457 10721010 |
MESH:D000544 |
Alzheimer Disease |
|
Copper |
6.84 | 17119284 16886094 16325427 16410023 16866297 16962711 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
6.84 | 15800139 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
4.23 | 10694572 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.35 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.35 | 11748828 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
4.78 | 16614410 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.36 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.60 | 15885639 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.91 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.94 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.69 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.37 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Copper |
4.46 | 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Copper |
2.32 | 15986119 17079463 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.32 | 15136595 16110121 19217205 16595493 18608205 16557594 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.32 | 16837676 17952589 16912660 17049068 15572757 17242785 17595753 17893378 17261762 15758505 17440819 15775269 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.32 | 19200415 19011961 21138602 19189212 19289846 18855134 20065188 17893378 21152245 18629630 20005174 18815881 17049068 15565566 20390343 19189210 18984771 18351453 19487384 20135344 17440819 19288272 17242785 20544844 19244106 20859285 16818667 15668708 17261762 19084267 16873071 19221464 18425577 11161223 18821012 19115204 18997820 19155303 19066611 19142967 19410462 16273361 19059307 19103187 16202921 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.56 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.89 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.89 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.40 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
11.16 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
11.16 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
11.16 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
11.16 | 17971768 18930000 17088986 16332177 16799960 17045692 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
11.16 | 17173139 20935162 6705139 20007298 1701930 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
11.16 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.33 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.33 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.46 | 16280240 18986760 17066447 16757204 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.17 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.17 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Copper |
6.86 | 17327471 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.86 | 18850075 16120746 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.37 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
10.70 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
10.70 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.70 | 12371664 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.14 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
18.64 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
18.64 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
18.64 | 17681005 11677210 16105132 15861022 16919318 17110522 17333356 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
18.64 | 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.06 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.51 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
3.90 | 17169374 18772588 15001691 17018589 16510598 17287894 17725105 17016597 17172411 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
3.90 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.68 | 18949393 16303861 18288408 16524972 14970324 18383874 17094418 16331619 17695437 17401013 18802399 20501625 15289873 15148649 17594712 16282729 16391804 18509181 18448328 17454858 17255274 17016601 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
3.68 | 18259882 18509181 16391804 17454858 15273666 16303861 17159606 |
MESH:D015179 |
Colorectal Neoplasms |
|
Leucovorin |
3.68 | 17401013 17255274 16303861 17594712 17454858 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Leucovorin |
3.05 | 16925845 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.53 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.53 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.68 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.25 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.07 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.70 | 12868966 2524372 11906362 14531868 8156756 8970840 18759878 11298694 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.39 | 2952479 3621924 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.72 | 17451421 17308373 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.72 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.69 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.69 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.69 | 18692083 7440962 11289319 9653073 18289764 1440618 6482804 9328219 18648102 9022650 8291058 6679447 16192314 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.69 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Gentamicins |
8.12 | 15033597 11033412 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.12 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.90 | 1851702 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.52 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.52 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.80 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.73 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
14.73 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.73 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
2.97 | 19155303 16202921 20544844 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.00 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.77 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.83 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.45 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.14 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.91 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.43 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.43 | 16481741 15173087 16785472 16337965 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
17.94 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
17.94 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
17.94 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
17.94 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.17 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.91 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.42 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.07 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.12 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.12 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.11 | 8708960 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.83 | 16145905 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.93 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.31 | 18337622 15162350 15102660 |
MESH:D034381 |
Hearing Loss |
|
Gentamicins |
4.79 | 19130971 18024279 17868369 15968427 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.27 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.46 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.31 | 15720958 |
MESH:D006467 |
Hemophilia A |
marker/mechanism |
|
| 11918545 16051741 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.41 | 6705139 |
MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
5.17 | 17338147 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
5.06 | 16607473 17182432 17276780 17109627 19888908 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
8.08 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.08 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 18606429 8697196 16354765 15340226 16959395 |
MESH:D053565 |
Hypercalciuria |
|
Gentamicins |
5.60 | 17652376 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.83 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.34 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.34 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.34 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.70 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.36 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.41 | 17937319 |
MESH:D007249 |
Inflammation |
|
Aluminum |
8.15 | 16052892 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.15 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.15 | 12200463 12878042 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.91 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.23 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.34 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Gentamicins |
5.62 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.18 | 10903974 18776723 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Gentamicins |
6.18 | 18289764 17934191 19349640 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
4.80 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
27.92 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
27.92 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
27.92 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
27.92 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
27.92 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
27.92 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
11.75 | 16316344 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Gentamicins |
11.75 | 11231351 |
MESH:D007859 |
Learning Disorders |
|
Copper |
4.68 | 17134702 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.39 | 16973256 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Gentamicins |
4.37 | 10219319 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.08 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.83 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.13 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.25 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.25 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.15 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
17.46 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Copper |
17.46 | 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
17.46 | 17045692 15113037 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
17.46 | 19812893 19073162 8742319 19482888 15975961 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
17.46 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
17.46 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
13.54 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
13.54 | 1399818 6587162 598648 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
13.54 | 1399818 18308698 17172636 2563599 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
13.54 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Aluminum |
4.57 | 16052892 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
3.33 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.33 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.33 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.68 | 15086387 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.65 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.55 | 11731420 16827153 14580682 19196722 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.44 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.87 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.07 | 15990972 |
MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.77 | 17109627 17268249 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.68 | 16801185 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.45 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.55 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
irinotecan |
4.90 | 17159606 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.36 | 16497877 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Aluminum |
6.27 | 17086897 |
MESH:D020529 |
Multiple Sclerosis, Relapsing-Remitting |
|
Aluminum |
6.27 | 17086897 |
MESH:D009137 |
Muscular Dystrophy, Animal |
|
Gentamicins |
6.17 | 18694830 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.93 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.37 | 17484760 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.45 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.98 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.98 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.29 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
9.29 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
9.29 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.48 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.56 | 16928823 18600527 18239605 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.89 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
4.84 | 17308104 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.34 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.19 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.11 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.84 | 6679447 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.42 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
4.62 | 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.36 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
14.50 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
14.50 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
14.50 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.91 | 3988306 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.26 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
11.80 | 17882678 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
11.80 | 12665316 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
11.80 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.12 | 17823083 15579764 15758505 17893378 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.22 | 16929163 19003803 16500647 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.22 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.58 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.38 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.36 | 6228378 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
ethinyl estradiol-desogestrel combination |
5.50 | 17105841 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.65 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.65 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.08 | 11222880 11896295 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
2.17 | 17308104 17079463 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.17 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.17 | 16536755 15731164 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.17 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Gentamicins |
4.62 | 15033597 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
9.64 | 16919318 15861022 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
9.64 | 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.39 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.19 | 16882103 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.45 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.92 | 18722050 18286688 15538739 16160472 |
MESH:D051437 |
Renal Insufficiency |
|
Gentamicins |
4.88 | 17132701 15728788 |
MESH:D015427 |
Reperfusion Injury |
|
Leucovorin |
4.54 | 17295595 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.29 | 3692021 |
MESH:D012173 |
Retinitis |
|
Gentamicins |
6.17 | 18644591 |
MESH:D012559 |
Schizophrenia |
|
Copper |
3.07 | 16842975 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.37 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.37 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
9.37 | 3137016 16876388 4039156 11442880 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.71 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.99 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.21 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.21 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.93 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.69 | 19084572 16424979 18567086 18396642 19015929 17522103 17498489 17172411 16951190 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.69 | 15723263 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.73 | 16837676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
17.87 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
ethinyl estradiol-desogestrel combination |
17.87 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Gestodene |
17.87 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
9.23 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Gestodene |
9.23 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.86 | 7505956 3712494 1399818 6582329 6587162 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
6.86 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.10 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.89 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
15.35 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
15.35 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
15.35 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
15.35 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
15.35 | 16712894 8653321 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.63 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.63 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.78 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.19 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.88 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.10 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
marker/mechanism |
|
| 16875063 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
17.35 | 14671159 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
ethinyl estradiol-desogestrel combination |
17.35 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
17.35 | 15869587 |
MESH:D015837 |
Vestibular Diseases |
|
Gentamicins |
5.41 | 18776599 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.45 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.34 | 17120751 |